Welcome to our dedicated page for Diversified Healthcare Tr SEC filings (Ticker: DHCNI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Diversified Healthcare Tr's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Diversified Healthcare Tr's regulatory disclosures and financial reporting.
Diversified Healthcare Trust is asking shareholders to vote at its virtual 2026 annual meeting on June 10 on three items: elect seven trustees, approve executive compensation on an advisory basis, and ratify Deloitte & Touche as auditor.
The proxy highlights 2025 actions: sale of 69 non-core properties for about $605 million, using proceeds and cash on hand to fully repay 2026 zero coupon senior secured notes, leaving no debt maturities until 2028. The company also transitioned 116 senior housing operating communities to new managers, expects improvements in occupancy, rates and NOI, and reports it was the top-performing U.S. REIT in 2025 with total shareholder return of roughly 113%.
The filing details a seven-member board with five independent trustees, a lead independent trustee role, committee structures, shareholder engagement, and extensive sustainability and SASB-aligned metrics on energy, water, climate risk and tenant engagement, along with trustee compensation and ownership guidelines.
Diversified Healthcare Trust filed a current report stating that it has posted a new investor presentation on its website. The presentation, dated February 24, 2026, is included as Exhibit 99.1 and is furnished as part of the disclosure to provide investors with updated information about the company.
Diversified Healthcare Trust reported a Q4 2025 net loss of $21.2 million, or $0.09 per share, but significantly stronger cash metrics, including normalized FFO of $21.8 million, or $0.09 per share, and Adjusted EBITDAre of $72.4 million. Same property senior housing operating portfolio (SHOP) cash NOI rose 27.6% year over year to $38.3 million, driven by 82.4% occupancy and a 5.8% increase in average monthly rates. The medical office and life science portfolio generated same property cash NOI of $24.1 million with 94.7% occupancy.
For full year 2025, DHC posted a net loss of $285.9 million, impacted by $165.7 million of impairments and high interest expense, while normalized FFO improved to $64.4 million. Management highlighted approximately $6.3 billion of real estate across 298 properties and noted it fully redeemed its zero‑coupon notes due 2026, reducing net debt to annualized Adjusted EBITDAre to 8.1x. The company issued 2026 guidance calling for NOI of $297–$313 million, Adjusted EBITDAre of $290–$305 million, and normalized FFO of $125–$140 million, with expected SHOP NOI growth of 26%–33%.